AB Science S.A. (EPA:AB)
France · Delayed Price · Currency is EUR 0.6120
+0.0710 (13.12%)
Aug 3, 2026, 2:51 PM CET
AB Science Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.18 | 7.99 | 6.07 | 7.27 | 8.72 |
Cash & Short-Term Investments | 10.18 | 7.99 | 6.07 | 7.27 | 8.72 |
Cash Growth | 27.45% | 31.67% | -16.55% | -16.65% | -57.70% |
Accounts Receivable | 0.34 | 0.13 | 0.24 | 0.16 | 0.31 |
Total Trade Receivables | 0.34 | 0.13 | 0.24 | 0.16 | 0.31 |
Inventory | 0.15 | 0.18 | 0.34 | 0.46 | 0.14 |
Other Current Assets | 3.54 | 6.22 | 12.75 | 12.99 | 9.02 |
Total Current Assets | 14.2 | 14.52 | 19.39 | 20.87 | 18.19 |
Net Property, Plant & Equipment | 1 | 0.9 | 0.79 | 1.27 | 1.59 |
Other Intangible Assets | 1.57 | 1.33 | 1.4 | 1.63 | 1.42 |
Long-Term Investments | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 |
Other Long-Term Assets | 7.7 | 6.36 | 3.84 | 0 | 0 |
Total Assets | 24.53 | 23.18 | 25.5 | 23.84 | 21.27 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.3 | 10.03 | 11.08 | 12.25 | 11.37 |
Accrued Expenses | 0.32 | 0.65 | 0.66 | 0.39 | 1.27 |
Short-Term Debt | 0.7 | 3.81 | 1.91 | 4.33 | 0.25 |
Current Portion of Leases | 0.12 | 0.12 | 0.21 | 0.36 | 0.38 |
Other Current Liabilities | 4.38 | 5.83 | 4.83 | 5.74 | 4.22 |
Total Current Liabilities | 14.82 | 20.43 | 18.68 | 23.08 | 17.48 |
Long-Term Debt | 25.41 | 25.14 | 26.67 | 34.56 | 24.87 |
Long-Term Leases | 0.71 | 0.54 | 0.38 | 0.7 | 1.04 |
Other Long-Term Liabilities | 0.79 | 0.82 | 0.77 | 1.17 | 1.08 |
Total Long-Term Liabilities | 26.91 | 26.5 | 27.83 | 36.43 | 26.99 |
Total Liabilities | 41.72 | 46.93 | 46.51 | 59.51 | 21.27 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.66 | 0.58 | 0.51 | 0.47 | 0.47 |
Additional Paid-in Capital | 279.86 | 271.52 | 256.68 | 233.93 | 233.92 |
Accumulated Other Comprehensive Income | -0.04 | -0.07 | -0.07 | -0.08 | -0.07 |
Retained Earnings | -297.68 | -295.78 | -278.13 | -269.99 | -257.52 |
Shareholders' Equity | -17.2 | -23.75 | -21.01 | -35.67 | -23.2 |
Total Liabilities & Equity | 24.53 | 23.18 | 25.5 | 23.84 | -1.93 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 26.94 | 29.61 | 29.17 | 39.96 | 26.53 |
Net Cash (Debt) | -16.76 | -21.62 | -23.1 | -32.69 | -17.81 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.27 | -0.41 | -0.34 | -0.52 | -0.27 |
Book Value | -17.2 | -23.75 | -21.01 | -35.67 | -23.2 |
Book Value Per Share | -0.28 | -0.45 | -0.31 | -0.56 | -0.36 |
Tangible Book Value | -18.77 | -25.08 | -22.41 | -37.3 | -24.62 |
Tangible Book Value Per Share | -0.31 | -0.47 | -0.33 | -0.59 | -0.38 |